Adeberg
banner
adeberg.bsky.social
Adeberg
@adeberg.bsky.social
57 followers 170 following 18 posts
☢️⚡️Radiation oncologist, medical scientist and athlete – passionate about innovations and transformation in healthcare. I share insights into cancer research, health strategies, and the future of personalized medicine. 🎯 mit-marburg.de/
Posts Media Videos Starter Packs
Pinned
🔥Dose-escalation studies in prostate cancer:

Studies with escalated external beam radiotherapy, targeting the whole prostate gland, showed improved bcFS, MFS and OS

📈Overview on FLAME trials (2021) Hypofx regimens were not mentioned as standard at that time.

#radonc #urology #healthcare
Reposted by Adeberg
JAMA @jama.com · 1d
Uveitis is a condition involving inflammation in the uvea (the middle portion of the eye).

📝 This JAMA Patient Page describes types of uveitis, ages and conditions associated with uveitis, and diagnosis and treatment.

ja.ma/48TW7a4
Reposted by Adeberg
In the TeMPO trial, reduction in knee pain at 3 months was similar in participants assigned to home exercise alone and those assigned to home exercise, motivational text messages, and standard physical therapy. Full trial results: nej.md/4ofjqQt

#MedSky #Rheumatology
Reposted by Adeberg
Analyses of U.K. Biobank and clinical cohorts show that rare genetic diseases can be misdiagnosed as common diseases, which may have implications for clinical trials as well as for diagnosis and treatment. Full study results: nej.md/3Jk1MvD

#MedSky #Genetics
Incredible - 34thousand participants in Berlin💪🏻
🎥 50 years of key moments.

ESMO’s 50th anniversary marks decades of achievements in #ScienceDissemination, #education and #collaboration. Take a selfie and share one of your milestones with #myESMOStory. #ESMO25

🔗 www.youtube.com/watch?v=dJTH...
Reposted by Adeberg
#ESMO25: 177Lu-PSMA-617 with ADT plus ARPI showed PFS benefit in hormone-sensitive #ProstateCancer (#HSPC) but no improvement seen with 177Lu-PSMA-617 vs docetaxel in castration-resistant prostate cancer (#mCRPC) after ARPI.
#ESMODailyReporter ➡️ https://ow.ly/2C0e50XeAoj

📈Great Posters: EURO-ACT study atlas & ACCEPT program for Lung cancer patients

#ESMO2025 #ProstateCancer #NSCLC #RadiationOncology #Immunotherapy #ClinicalTrials
🫁 SKYSCRAPER-03 (Stage III NSCLC): Atezo+tira fails to beat durva after cCRT → durvalumab remains #standard.

MDT-BRIDGE (neo-IO NSCLC): High resection (85.7%) and R0 rates with close MDT guidance → more patients reach curative local #therapy.
#radonc Highlights from the last 24 hours at ESMO #Berlin 🚀

🌰ENZARAD (high-risk PCa): No overall MFS benefit with ENZA, but clear gains in cN1 & pelvic-RT subgroups.Selective intensification may matter

EMBARK (hrBCR PCa): Enza + ADT cuts mortality risk by ~40% vs ADT alone → a new standard of care
👇NorthStar trial - #ESMO highlight 17.10.

🧠 LCT improved PFS across subgroups
🌐 Even with >3 mets (20.7 vs 15.9 mo)
🧬 EGFR ex19del: 39.8 vs 22.8 mo
🔬 L858Rmut: 19.1 vs 11.0 mo
💪 Comprehensive vs partial LCT: 33.1 vs 15.1 mo

dailyreporter.esmo.org

@myesmo.bsky.social @astro-org.bsky.social
It was a pleasure to welcome the Nursing Directorate of Asklepios 👩‍⚕️👨‍⚕️ to our MIT - Marburg Ion-beam Therapy Center @ukgm.bsky.social 🏥!

Thx for the open discussions and the practical perspectives with a clear focus on #patientcare 💙.

#Healthcare #Collaboration #Innovation #HealthCareManagement
🌿 Science, collaboration & inspiration at Castle Rauischholzhausen 🏰 At the #ADMIT Summer School we explored medical physics & RT, shared ideas across disciplines & returned with fresh energy ✨ #Oncology #MedicalPhysics #Innovation

@ukgm.bsky.social @physics.bsky.social @unimarburg.bsky.social
👉 My Key Takeaway:
Old process + expensive tech = expensive old process.

True progress needs smart redesign – not just digital tools, but digitally enabled workflows.

#DigitalHealth #Collaboration

@unimarburg.bsky.social @asklepiosgarden.bsky.social
Impressions of DEGRO 2025

Meeting friend of the #radonc #family!

With 43 talks and posters from doctoral students to group leaders we had a busy schedule💪🏻

#Team #Marburg
#oncology
Reposted by Adeberg
Welcome to the Science feed!

Please read our FAQs for instructions for how to be added as a contributor: bossett.io/science-feed/

Mod introductory posts linked below⬇️

Use the test tube emoji on posts you want to appear in the feed🧪

Please like the feed and make sure you follow our feed rules:
Very interesting Cosima! #AI guided decision-making in boards is going to be the near #future🦾

We are already using it at Need.com when generating interdisciplinary treatment recommendations for #cancer patients📊

Careful #human supervision is still necessary🧐

pubmed.ncbi.nlm.nih.gov/40281318/
🔥Dose-escalation studies in prostate cancer:

Studies with escalated external beam radiotherapy, targeting the whole prostate gland, showed improved bcFS, MFS and OS

📈Overview on FLAME trials (2021) Hypofx regimens were not mentioned as standard at that time.

#radonc #urology #healthcare
Reposted by Adeberg
“Although it is still unclear precisely how herpes zoster vaccination lowers the risk of dementia, the implications of the study are profound.The vaccine could represent a cost-effective intervention that has public-health benefits”
#Dementia #Shingles #Vaccination 🧪
www.nature.com/articles/d41...
Could the shingles vaccine help to prevent dementia?
Large-scale analyses of electronic health data suggest that the herpes zoster vaccine could protect against dementia — but it’s not yet clear how.
www.nature.com
Sure! Check out the profvalmed.com., where we built a digital learning platform providing knowledge for healthcare professionals about medical knowledge and the link to AI. It offers CME accredited courses for both beginners and experts.
Prof. Valmed – We provide validated information for healthcare professionals.
Prof. Valmed is the pioneering tool that provides healthcare professionals with validated medical information through innovative AI technology as the medical co-pilot.
profvalmed.com
Reposted by Adeberg
Wow. Bluesky has become the platform where science happens 💫🤩🧪
THREAD

The numbers are in. @bsky.app research sharing volumes vs X Formerly Twitter

In March 2024, on most days, Bluesky hosts more posts linked to research published in 2025 than X.

By quite a lot.

Release the Kraken...

#AcademicSky #HigherEd #Altmetrics
1/11
@stefanbuttigieg.com hey, could you add me to your AI list! Thanks from Germany. Sebastian
@morganslevy.bsky.social hey, could you add me to the radiation oncology list! Thanks from Germany. Sebastian